3-hydroxy-3-methyl-glutaryl CoA: Difference between revisions
Jump to navigation
Jump to search
imported>David E. Volk (New page: {{subpages}} [[Image:Mevalonate synthesis.jpg|right|thumb|250px|{{#ifexist:Template:Mevalonate synthesis.jpg/credit|{{Mevalonate synthesis.jpg/credit}}<br/>|}}Biosynthesis of mevalonate fr...) |
mNo edit summary |
||
| (3 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
{{subpages}} | {{subpages}} | ||
{{Image|Mevalonate synthesis.jpg|right|250px|Biosynthesis of mevalonate from HMG CoA.}} | |||
The biochemical '''3-hydroxy-3-methyl-glutaryl CoA''' | The biochemical '''3-hydroxy-3-methyl-glutaryl CoA''' '''(HMG CoA)''', is a chemical precursor of [[mevalonate]], which is a key metabolite in the synthesis of [[cholesterol]]. The cholesterol-lowering statins, such as [[Lipitor]] and [[Crestor]], among others, are [[Hydroxymethylglutaryl-coenzyme A reductase inhibitor|HMG-CoA reductase inhibitor]]s which block the synthesis of mevalonate from HMG CoA.[[Category:Suggestion Bot Tag]] | ||
Latest revision as of 06:01, 4 July 2024
The biochemical 3-hydroxy-3-methyl-glutaryl CoA (HMG CoA), is a chemical precursor of mevalonate, which is a key metabolite in the synthesis of cholesterol. The cholesterol-lowering statins, such as Lipitor and Crestor, among others, are HMG-CoA reductase inhibitors which block the synthesis of mevalonate from HMG CoA.